Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study

PURPOSE: To assess the one-year effectiveness and safety of ranibizumab 0.5 mg in treatment- naïve patients with diabetic macular edema (DME) enrolled in the real-world LUMINOUS study. PATIENTS AND METHODS: A 5-year, prospective, observational, open-label, global study which recruited 30,138 patient...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:PLoS One
المؤلفون الرئيسيون: Mitchell, Paul, Sheidow, Tom G., Farah, Michel E., Mahmood, Sajjad, Minnella, Angelo M., Eter, Nicole, Eldem, Bora, Al-Dhibi, Hassan, Macfadden, Wayne, Parikh, Soumil, Dunger-Baldauf, Cornelia, Mahgoub, Mohamed M., Schmidt-Erfurth, Ursula
التنسيق: Artigo
اللغة:Inglês
منشور في: Public Library of Science 2020
الموضوعات:
Research Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269267/
https://ncbi.nlm.nih.gov/pubmed/32492069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233595
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة